Understanding and reversing abnormal brain activity in Alzheimer's Disease

Identifying the mechanistic role of and reversing aberrant neural activity in Alzheimer's Disease

NIH-funded research Stanford University · NIH-10896399

This study is looking at how unusual brain activity affects Alzheimer's Disease and is trying to find ways to fix it, so it’s for anyone interested in understanding more about the disease and how we might be able to detect and treat it earlier.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-10896399 on NIH RePORTER

What this research studies

This research investigates how abnormal neural activity contributes to Alzheimer's Disease and explores potential therapeutic approaches to reverse this activity. By using advanced techniques like 2-photon imaging, the study aims to identify specific patterns of neural dysfunction that may lead to cognitive decline. The research focuses on understanding the relationship between amyloid-beta and tau proteins and their impact on brain activity, which could provide insights into earlier detection and treatment of the disease.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's Disease or those in the early stages of cognitive decline.

Not a fit: Patients with advanced Alzheimer's Disease or those with other forms of dementia may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that improve cognitive function in patients with Alzheimer's Disease.

How similar studies have performed: Other research has shown promise in targeting neural activity to improve cognitive outcomes, suggesting that this approach could be effective.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.